Introduction

SINGAPORE – Exciting news for residents! A revolutionary self-test kit that allows at-home screening for Covid-19 and influenza A and B has officially hit the shelves in Singapore.

Features of the Self-Test Kit

This innovative 3-in-1 test is akin to a standard Covid-19 antigen rapid test kit but boasts the remarkable capability of detecting not only Covid-19 but also the two prevalent strains of the flu. With results available in a mere 10 minutes, users can swiftly check their health status using just a single nasal swab, according to the manufacturer, CorDx.

Product Launch

Angel Tan, the general manager of CorDx, announced that the product, named the CorDx Tyfast Flu A/B & Covid-19 Multiplex Rapid Test, received approval for self-testing on February 14, 2025. Consumers can purchase it for $9.80 per kit through the online CorDxstore, and it is also available at popular retail chains such as Watsons and Unity Pharmacy, as well as healthcare touchpoints like the National Healthcare Group polyclinics and the National University Health System polyclinics.

Market Positioning and Regulations

While the CorDx self-test is not the only kit registered in Singapore, it stands out as the sole one approved for self-testing. The Health Sciences Authority (HSA) has registered a total of 10 combination test kits, with nine of these designated for professional use only, requiring qualified healthcare professionals for administration.

Design and Accessibility

Self-test kits like this are designed with simplicity in mind, featuring clear instructions that make them accessible to everyday users. They provide rapid results, which are crucial for effective infection detection, aligning with international standards. Typically, the sensitivity of such devices – their ability to accurately identify positive infections – ranges from 80% to 99%, as stated by an HSA spokesperson.

Healthcare Impact

Influenza A and B virus infections are a year-round concern in Singapore, with increased activity noted during specific peaks throughout the year. Dr. Lim Wee Peng, medical director at Parkway Shenton, shared that the general practitioner chain has been utilizing the 3-in-1 kits since their launch in 2023 for diagnosing suspected cases of flu and Covid-19.

Importance of Early Diagnosis

These kits are particularly beneficial for patients displaying symptoms of upper respiratory infections, such as fever or elevated body temperature, during the initial days of their illness. Dr. Lim emphasized the challenge of distinguishing between flu and Covid-19 without testing since they share many symptoms.

Treatment Recommendations

“A confirmed diagnosis of influenza A/B allows our doctors to prescribe targeted antiviral treatments, which can significantly reduce symptom severity and duration when given early,” he explained. Additionally, timely Covid-19 detection facilitates appropriate isolation and management measures.

Public Benefits of Home Testing

For the general public, home testing not only offers convenience but also empowers users to differentiate between Covid-19, flu, and even common colds. Mild colds are usually far less concerning.

Expert Guidance

Dr. Lim urged that a positive result for flu A/B should prompt individuals to seek early antiviral treatment at a clinic, especially for those in high-risk categories, such as the elderly or those with chronic health conditions. The Ministry of Health guidelines recommend self-isolation and telemedicine consultations for Covid-19 cases. This proactive approach is essential for reducing community transmission and ensuring swift action.

User Instructions and Age Restrictions

The CorDx self-test is approved for home use, allowing individuals aged 14 and above to collect nasal swab specimens themselves. Additionally, adults can collect specimens from children aged two years and older.

Conclusion

In a world still grappling with the Covid-19 pandemic, this self-test kit offers an invaluable tool for managing public health, providing peace of mind, and empowering individuals to take charge of their health in these uncertain times. Don't miss out on this game-changing development!